Mercer Global Advisors’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.4M | Sell |
58,273
-6,882
| -11% | -$1.43M | 0.01% | 532 |
|
|
2026
Q1 | $14.6M | Sell |
65,155
-4,752
| -7% | -$1.18M | 0.02% | 403 |
|
|
2025
Q4 | $16.8M | Sell |
69,907
-6,650
| -9% | -$1.7M | 0.03% | 370 |
|
|
2025
Q3 | $21M | Sell |
76,557
-465
| -0.6% | -$127K | 0.04% | 301 |
|
|
2025
Q2 | $19.9M | Buy |
77,022
+10,345
| +16% | +$2.47M | 0.04% | 246 |
|
|
2025
Q1 | $14.9M | Buy |
66,677
+46,578
| +232% | +$10.9M | 0.03% | 278 |
|
|
2024
Q4 | $4.6M | Buy |
20,099
+1,249
| +7% | +$301K | 0.01% | 563 |
|
|
2024
Q3 | $4.5M | Buy |
18,850
+13,026
| +224% | +$2.91M | 0.01% | 522 |
|
|
2024
Q2 | $1.09M | Sell |
5,824
-270
| -4% | -$54.8K | ﹤0.01% | 931 |
|
|
2024
Q1 | $1.2M | Buy |
6,094
+2,450
| +67% | +$449K | ﹤0.01% | 893 |
|
|
2023
Q4 | $627K | Sell |
3,644
-309
| -8% | -$47.5K | ﹤0.01% | 1188 |
|
|
2023
Q3 | $584K | Sell |
3,953
-76
| -2% | -$13.7K | ﹤0.01% | 1176 |
|
|
2023
Q2 | $880K | Buy |
4,029
+62
| +2% | +$13.8K | ﹤0.01% | 988 |
|
|
2023
Q1 | $869K | Sell |
3,967
-810
| -17% | -$176K | ﹤0.01% | 964 |
|
|
2022
Q4 | $994K | Buy |
4,777
+61
| +1% | +$13.4K | 0.01% | 916 |
|
|
2022
Q3 | $1.03M | Sell |
4,716
-68
| -1% | -$15.5K | 0.01% | 831 |
|
|
2022
Q2 | $1M | Buy |
4,784
+790
| +20% | +$168K | 0.01% | 845 |
|
|
2022
Q1 | $969K | Sell |
3,994
-295
| -7% | -$71.4K | 0.01% | 912 |
|
|
2021
Q4 | $1.12M | Buy |
4,289
+21
| +0.5% | +$5.45K | 0.01% | 834 |
|
|
2021
Q3 | $1.13M | Sell |
4,268
-3
| -0.1% | -$820 | 0.01% | 805 |
|
|
2021
Q2 | $1.05M | Buy |
4,271
+88
| +2% | +$18.5K | 0.01% | 811 |
|
|
2021
Q1 | $812K | Buy |
4,183
+317
| +8% | +$63.6K | 0.01% | 871 |
|
|
2020
Q4 | $822K | Buy |
3,866
+880
| +29% | +$175K | 0.01% | 672 |
|
|
2020
Q3 | $512K | Buy |
2,986
+221
| +8% | +$40.8K | 0.01% | 775 |
|
|
2020
Q2 | $531K | Sell |
2,765
-1
| -0% | -$164 | 0.01% | 661 |
|
|
2020
Q1 | $407K | Buy |
2,766
+1,013
| +58% | +$161K | 0.01% | 722 |
|
|
2019
Q4 | $272K | Sell |
1,753
-27
| -2% | -$3.89K | 0.01% | 955 |
|
|
2019
Q3 | $240K | Buy |
1,780
+22
| +1% | +$2.88K | 0.01% | 975 |
|
|
2019
Q2 | $215K | Sell |
1,758
-187
| -10% | -$20.7K | 0.01% | 1023 |
|
|
2019
Q1 | $202K | Buy |
+1,945
| New | +$201K | 0.01% | 983 |
|
Other funds holding RMD
Mercer Global Advisors's RMD Position: Q2 2026 in Review
Mercer Global Advisors reduced its ResMed (RMD) stake by 11% in Q2 2026, selling an estimated $1.43M and leaving 58,273 shares worth $11.4M. The position accounts for 0.01% of the portfolio, ranked #532.
Mercer Global Advisors first reported a position in RMD in Q1 2019 and has held it in 30 quarters since. The position peaked at $21M in Q3 2025. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Mercer Global Advisors held 58,273 shares of ResMed worth $11.4M as of Q2 2026.
- Mercer Global Advisors sold 6,882 ResMed shares in Q2 2026, an estimated $1.43M.
- ResMed made up 0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #532 holding.
- Mercer Global Advisors first reported a position in ResMed in Q1 2019 and has held it in 30 quarters since.
- Mercer Global Advisors's ResMed position peaked at $21M in Q3 2025.
- 888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.